/
Login
Analysis Scores
Damodaran ?
26/100
Dalio Risk ?
73/100
Piotroski ?
6/9
Neutral
Operating cash flow data missing (C3, C4)
Graham ?
A$20.3
Pahalı
Active Metric?
4/4
Confidence?
72%
Valuation
Potential?
-24.7%
ROIC ?
4.0%
DCF Value ?
23.35
Debt Cycle?
Early Expansion
Data
Data ?
9750
1988-01-29 → 2026-09-02
Risk Analysis (VaR)
Orta
252 days
Annual Volatility ?
%26.6
VaR 95% ?
%2.66
daily max loss
VaR 99% ?
%3.80
daily max loss
CVaR 95% ?
%3.57
expected loss (tail)
Max Drawdown ?
%33.2
28.11.2025 → 18.05.2026
Skewness ?
0.90
Parametrik%2.66
Historik%2.49
Cornish-Fisher%1.99
Return Distribution
Fundamental & Technical Analysis
TRAMA-99 Trend — Strong Uptrend
Price (41.44), TRAMA-99 line's %18.0 above. Strong uptrend continues. Technical momentum positive.
Price:: 41.439998626708984
TRAMA: 35.1281
Difference: %+18.0
Profitability
Net Profit Margin
%5.1
Net profit margin %5.1 — positive but low. Compared to previous quarter +0.0 point increase.
ROE – Özkaynak Getirisi (TTM)
%2.6
ROE %2.6 — low return on equity.
EBITDA Margin
%13.0
EBITDA margin %13.0 — moderate operational efficiency.
Gross Profit Margin
%41.2
Gross profit per revenue %41.2. Strong pricing power.
Free Cash Flow Margin (TTM)
%8.5
TTM Free Cash Flow is %8.5'i. Moderate FCF — capex constraining operational profit.
Valuation
P/E Ratio
40.1x
Sector: 15.9x
F/K 40.1x — sector median's (15.9x) %153 above. Expensive zone.
P/B Ratio
2.08x
Sector: 2.80x
PD/DD 2.08x — sector median (2.80x) below or near. Reasonable valuation.
EV/EBITDA
17.8x
Sector: 5.6x
EV/EBITDA 17.8x — sector median's (5.6x) %218 above. EBITDA’ya göre pahalı.
Indebtedness
Current Ratio
2.13x
Current ratio 2.13x — current assets are 2x short-term liabilities. Very healthy liquidity.
Net Debt / EBITDA
3.1x
Net Borç/EBITDA 3.1x — high debt burden. Borç servisi baskı oluşturuyor.
Debt / Equity
0.41x
Low leverage — majority of assets financed by equity.
Interest Coverage
5.7x
Interest coverage 5.7x — interest obligations comfortably covered.
Growth
Revenue Growth (YoY)
%+23.7
Revenue YoY %23.7 grew — healthy growth rate.
Net Profit Growth (YoY)
%+32.8
Net profit YoY %32.8 increased — strong profit growth.
Score Explanations
Lothien Robustness
44/100
Moderate robustness (44/100). Valuation and risk criteria give mixed signals. Detailed review recommended.
Moderate
Potential
-24.7%
Minus %24.7 expected value (30.71) vs current price comparison. 4/4 valuation models give 'BUY' signal. Model confidence %72.
Components: PE target: 16.50 | P/B target: 55.87 | EV/EBITDA target: 12.84 | DCF target: 23.35
Damodaran Valuation
26/100
Low Damodaran score (26/100). ROIC (%4.0) below cost of capital. DCF analysis does not support current price.
Very Weak
Dalio Risk Analysis
73/100
Low debt risk (73/100). Interest coverage ratio 5.7x — strong. Borç/EBITDA 3.1x — manageable.
Leverage: 76/100 | Debt Service: 98/100 | Quality: 75/100
ROIC – Sermaye Getirisi
%4.0
ROIC (%4.0) cost of capitaln (11.0%) below → destroying value.
WACC: %11.0
DCF Discounted Cash Flow
23.35
DCF (23.35) current price %42.7 below — cash flows do not support current price.
Current price: 40.77
Debt Cycle Phase
Early Expansion
Debt decreasing, growth gaining momentum. Company in balance sheet cleanup phase.
Piotroski F-Score
6/9
Moderate Piotroski (6/9). Some balance sheet criteria met, some missing. Note: Operating cash flow data missing (C3, C4)
Neutral
Graham Intrinsic Value
A$20.3
Graham intrinsic value: A$20.3. Pahalı
Expensive
⚖️ Sector Comparison
P/E Ratio
40.1x
vs 15.9x
Sector mediannın %153 above — expensive
P/B Ratio
2.08x
vs 2.80x
Compared to sector %26 cheaper (by book value)
EV/EBITDA
17.8x
vs 5.6x
Compared to sector %218 higher EV/EBITDA
ROIC vs WACC
%4.0
vs %11.0 WACC
ROIC 7.0 baz puan cost of capitaln altında
Net Profit Margin (TTM)
%5.1
vs %13.0 EBITDA margin
TTM net profit margin %5.1
Charts
Indicators
BB deviation
?
RSI thresholds
?
ANN — Participation Finance Compliance
Loading…
The Lothien health scores and analyses on this page are for informational purposes only. They do not constitute investment advice. Please consult a licensed investment advisor before making investment decisions.